High-yield points
- Papile: I germinal matrix; II IVH; III IVH with dilatation; IV parenchymal (really PVHI, a venous infarct). Hydrocephalus follows grades III–IV (see caveats).
- Treat progressive PHVD early: VI over the 97th percentile and AHW over 6 mm (ELVIS). Death or disability was 35% vs 51% (aOR 0.24 in a post hoc adjusted analysis) ; NNT 7 in the Bayesian reanalysis .
- Temporize with a VAD or VSGS. With standardized criteria (SOPHH), the device doesn't matter (63.5% vs 74.0% conversion) . Don't let ventricles grow before conversion .
- DRIFT: fewer deaths or severe disabilities, and better cognition at 10 years (66% vs 35% without severe cognitive disability), at the cost of secondary bleeding .
- NEL: shunt dependence around 58–66%, infection lower than standard care, and the lowest shunt rate in TROPHY. Randomized data are pending (ENLIVEN-UK) .
Landmark papers
- ELVIS (de Vries et al. 2019; Cizmeci et al. 2020): a randomized trial of early (VI >97th percentile, AHW >6 mm) vs late intervention. Shunt or death didn't differ; for 2-year outcome, early treatment was favored in a post hoc adjusted analysis (aOR 0.24) .
- DRIFT (Whitelaw et al. 2010; Luyt et al. 2020): drainage, irrigation and fibrinolysis reduced death or severe disability (54% vs 71%), with a sustained cognitive benefit at 10 years .
- SOPHH (Wellons et al., J Neurosurg Pediatr 2017): with standardized HCRN decision rubrics, VSGS and reservoirs gave similar shunt-conversion rates (63.5% vs 74.0%) .
Intraventricular hemorrhage (IVH) is the classic brain injury of the preterm infant. It starts in the fragile germinal matrix next to the lateral ventricles, usually in the first days of life, and is most common in the smallest, most premature babies (see caveats).
High-grade IVH often leads to posthemorrhagic ventricular dilatation (PHVD), which can progress to posthemorrhagic hydrocephalus (PHH). PHH is one of the most common reasons for an infant shunt, and one of the hardest to manage well (see caveats).
The neurosurgeon's questions are:
- when to intervene;
- how to temporize until the baby is big enough for a shunt;
- whether to wash the blood out (DRIFT, neuroendoscopic lavage);
- how to shunt when it's needed.
Classification
- Papile grading (CT in 46 infants under 1,500 g) :
- 20 of 46 had IVH, and 7 of 9 surviving infants with IVH had no clinical signs, which is why routine screening matters;
- grades I and II resolved spontaneously;
- hydrocephalus developed after grade III and IV hemorrhage.
- The four grades (see caveats):
- I: germinal matrix (subependymal) hemorrhage only;
- II: IVH without ventricular dilatation;
- III: IVH with ventricular dilatation;
- IV: IVH with parenchymal hemorrhage.
- Grade IV is now usually called periventricular hemorrhagic infarction (PVHI). It is a venous infarction of the white matter from compression of the medullary veins, not an extension of the bleed. It predicts hemiparesis (see caveats).
- Screening: cranial ultrasound in the first week for very preterm infants, then serially (see caveats).
Monitoring ventricular size
- Ultrasound measures (see ventricular size calculator):
- ventricular index (VI): the distance from the midline to the lateral wall of the frontal horn, plotted on percentile charts by gestational age;
- anterior horn width (AHW);
- thalamo-occipital distance;
- fronto-occipital horn ratio (FOHR) (see caveats).
- Clinical signs: bulging fontanelle, split sutures, rapid head growth, apnea and bradycardia.
- Neurosurgeons agreed well on fontanelle and suture findings when using written definitions (κ 0.65 for a bulging fontanelle, 0.84 for split sutures) .
- Clinical signs come late in preterm infants. The compliant skull and large extracerebral spaces let the ventricles enlarge a lot before pressure signs appear, which is why ultrasound thresholds drive early treatment (see caveats).
Early vs late intervention: ELVIS
- Design (126 infants ≤34 weeks with grade III–IV IVH, 14 NICUs) :
- low threshold: VI over the 97th percentile and AHW over 6 mm;
- high threshold: VI over the 97th percentile + 4 mm and AHW over 10 mm;
- treatment: up to 3 lumbar punctures, then taps from a ventricular reservoir, then a VP shunt if the VI didn't stabilize.
- Primary outcome (shunt or death) :
- 30% low vs 37% high threshold, not significant;
- the low-threshold group had more procedures (LPs 97% vs 58%; reservoirs 62% vs 43%);
- shunt revision was more common in the low-threshold group (7 of 12 vs 1 of 14).
- 2-year outcome (113 of 126 assessed) :
- death, cerebral palsy, or Bayley cognitive or motor score below −2 SD: 35% low vs 51% high threshold (P = .07);
- in a post hoc adjusted analysis, the low threshold was associated with lower odds of the adverse outcome (aOR 0.24);
- infants with good outcomes had smaller FOHR at term;
- shunted infants in the low-threshold group did as well as unshunted ones, but those in the high-threshold group did worse.
- Bayesian reanalysis (2026) :
- late intervention carried a 91–99.7% probability of harm, with posterior OR 1.56–2.42 across priors;
- absolute risk difference 16%; number needed to treat 7;
- early intervention was associated with smaller ventricles and less brain injury on term MRI.
- Bottom line: treat progressive PHVD early, at VI over the 97th percentile with AHW over 6 mm, rather than waiting for clinical signs.
Temporizing devices and the SOPHH study
- Temporization keeps CSF under control until the baby can tolerate a shunt (see caveats for typical weight and protein thresholds):
- ventricular access device (VAD, reservoir) with intermittent tapping;
- ventriculosubgaleal shunt (VSGS);
- external ventricular drain.
- HCRN retrospective study (4 centers) :
- conversion to a permanent shunt: 86% after VSGS vs 69% after reservoir (P = .05);
- infection during temporization was similar (14% vs 13%).
- SOPHH: Shunting Outcomes in Posthemorrhagic Hydrocephalus (HCRN prospective cohort, 6 centers) :
- entry criteria:
- preterm, birth weight under 1,500 g, grade III or IV IVH, life expectancy over 72 hours ;
- a parallel HCRN biomarker cohort that followed the SOPHH parameters enrolled infants ≤34 weeks postmenstrual age with FOHR ≥0.50 ;
- the centers agreed a priori on standardized decision rubrics covering:
- when to treat the hydrocephalus surgically;
- upfront shunt vs temporization (VAD or VSGS);
- when to convert a temporizing device to a permanent shunt;
- standardized physical examination and surgical technique;
- compliance with the rubrics was 90%;
- results (145 infants):
- 28 never reached the threshold for treatment, 11 had an upfront shunt, 4 had ETV, and 102 were temporized (36 VSGS, 66 VAD);
- 180-day conversion to a permanent shunt: 63.5% after VSGS vs 74.0% after VAD (P = .36);
- infection 14% vs 17% (P = .71);
- conclusion: once decision-making is standardized, the choice of temporizing device doesn't change shunt rates. Earlier differences reflected center practice, not the device.
- Neurodevelopment in the HCRN cohort (106 infants) :
- initial permanent shunting went with lower cognitive scores than temporization (58 vs 69), though this is an observational comparison;
- temporized infants who were weaned off diversion did better on language than those converted to a shunt;
- VSGS and VAD gave similar outcomes;
- a larger ventricle size at conversion to a shunt was associated with worse motor scores, so don't let the ventricles grow while waiting to shunt.
Removing the blood: DRIFT
- The rationale: blood and its breakdown products (free iron, cytokines) injure the white matter and scar the CSF pathways. DRIFT aims to lower pressure, distortion, free iron and cytokines .
- The technique: intraventricular tPA, then continuous irrigation through two catheters with artificial CSF until the drainage is clear .
- Randomized trial (77 infants; DRIFT vs standard tapping) :
- death or severe disability at 2 years: 54% vs 71% (adjusted OR 0.25);
- severe cognitive disability in survivors: 31% vs 59% (adjusted OR 0.17);
- severe sensorimotor disability was not reduced;
- secondary intraventricular bleeding increased with DRIFT.
- 10-year follow-up (52 children assessed: 28 DRIFT, 24 standard) :
- mean cognitive quotient 69.3 vs 53.7 (adjusted P = .01);
- survival without severe cognitive disability: 66% vs 35%;
- the authors call DRIFT the first PHVD intervention with a proven, sustained cognitive benefit.
- Quality of life at 10 years (DRIFT cohort) :
- lower than peers on average, but with a wide range: about a quarter scored near population norms, and a fifth very low;
- grade IV hemorrhage carried worse quality of life than grade III.
- Why DRIFT didn't become standard: the secondary hemorrhage and the intensive-care burden of continuous irrigation (see caveats). Its success drove the move to neuroendoscopic lavage.
Neuroendoscopic lavage (NEL)
- The technique: an endoscope through a frontal burr hole into the lateral ventricle. Irrigate with warmed artificial CSF to wash out blood and debris under direct vision, and often fenestrate the septum. A VAD or VSGS is usually placed at the same sitting (see caveats).
- Meta-analysis of NEL alone (312 neonates, 9 studies) :
- shunt dependence 58%;
- infection 5.6%, multiloculated hydrocephalus 6.5%, mortality 2.4%.
- Second meta-analysis (299 neonates) :
- shunt dependence 66%;
- compared with standard temporization, shunt dependence trended lower (OR 0.51, P = .07), and infection was significantly lower (OR 0.14);
- 69% had a good motor outcome (GMFCS 1–2).
- TROPHY registry (238 neonates: 47 VAD, 34 EVD, 75 VSGS, 82 NEL; 6-month follow-up) :
- NEL had the lowest need for a permanent shunt, VSGS the highest;
- NEL had the least multiloculated hydrocephalus but the most frontal tissue defects at the entry point;
- complication and revision rates did not differ.
- The evidence gap: all of these are observational. ENLIVEN-UK is a randomized trial of NEL added to a temporizing device vs a device alone (planned 100 infants), with cognitive quotient at 2 years as the primary outcome .
Permanent shunting and alternatives
- When: persistent dependence on taps or drainage once the infant is large enough and the CSF is clear enough (see caveats; see surgical options in shunting).
- Expect trouble: PHH shunts have high failure and infection rates, and multiloculated hydrocephalus can develop (see caveats; see shunt failure).
- ETV with choroid plexus cauterization has lower success in PHH than in other infant etiologies (see ETV-CPC; see caveats).
Outcomes
- Grade I–II IVH: generally good. Grade III–IV and PVHI: high risk of cerebral palsy, cognitive impairment and epilepsy (see caveats).
- PHVD that needs treatment marks the highest-risk group. Outcomes are better with earlier treatment and blood removal .
- At 10 years, quality of life is lower than peers on average but varies widely .
Related topics
- Ventricular Size Calculator (FOHR, Evans Index, Neonatal Ventricular Index): ELVIS thresholds and measurement.
- Ventriculomegaly vs Hydrocephalus: when dilatation becomes hydrocephalus.
- Surgical Options in Shunting: permanent shunting in small infants.
- Shunt Failure: the high failure rate of PHH shunts.
- Efficacy of ETV-CPC in Infants: an alternative to shunting.
- Management of Hydrocephalus in Bacterial and Viral Meningitis: the other major acquired infant hydrocephalus.
- Programmable vs Nonprogrammable Shunt Valves: valve choice in PHH.
- Benign vs Malignant Macrocephaly: head growth in infants.
- Ventriculosubgaleal Shunt: temporizing with a subgaleal shunt.
- Lumbar Puncture in Children: serial taps.
- Ventriculoperitoneal Shunt Insertion: permanent shunting.
References
- Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92(4):529–534. doi:10.1016/s0022-3476(78)80282-080282-0). PMID 305471. verified
- Wellons JC, Holubkov R, Browd SR, et al. The assessment of bulging fontanel and splitting of sutures in premature infants: an interrater reliability study by the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 2013;11(1):12–14. doi:10.3171/2012.10.PEDS12329. PMID 23121114. verified
- de Vries LS, Groenendaal F, Liem KD, et al. Treatment thresholds for intervention in posthaemorrhagic ventricular dilation: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2019;104(1):F70–F75. doi:10.1136/archdischild-2017-314206. PMID 29440132. verified
- Cizmeci MN, Groenendaal F, Liem KD, et al. Randomized controlled early versus late ventricular intervention study in posthemorrhagic ventricular dilatation: outcome at 2 years. J Pediatr 2020;226:28–35.e3. doi:10.1016/j.jpeds.2020.08.014. PMID 32800815. verified
- Cizmeci MN, de Vries LS, Whitelaw A, et al. Early versus Late Ventricular Intervention Study (ELVIS) in post-hemorrhagic ventricular dilatation: Bayesian reanalysis of brain injury and outcomes. Pediatr Res 2026 (published online ahead of print). doi:10.1038/s41390-026-05172-4. PMID 42265277. verified
- Wellons JC, Shannon CN, Kulkarni AV, et al. A multicenter retrospective comparison of conversion from temporary to permanent cerebrospinal fluid diversion in very low birth weight infants with posthemorrhagic hydrocephalus. J Neurosurg Pediatr 2009;4(1):50–55. doi:10.3171/2009.2.PEDS08400. PMID 19569911. verified
- Wellons JC 3rd, Shannon CN, Holubkov R, et al. Shunting outcomes in posthemorrhagic hydrocephalus: results of a Hydrocephalus Clinical Research Network prospective cohort study. J Neurosurg Pediatr 2017;20(1):19–29. doi:10.3171/2017.1.PEDS16496. PMID 28452657. verified
- Limbrick DD, Morales DM, Shannon CN, et al. Cerebrospinal fluid NCAM-1 concentration is associated with neurodevelopmental outcome in post-hemorrhagic hydrocephalus of prematurity. PLoS One 2021;16(3):e0247749. doi:10.1371/journal.pone.0247749. PMID 33690655. verified
- Isaacs AM, Shannon CN, Browd SR, et al. Neurodevelopmental outcomes of permanent and temporary CSF diversion in posthemorrhagic hydrocephalus: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2025;35(4):315–326. doi:10.3171/2024.10.PEDS24257. PMID 39889292. verified
- Whitelaw A, Jary S, Kmita G, et al. Randomized trial of drainage, irrigation and fibrinolytic therapy for premature infants with posthemorrhagic ventricular dilatation: developmental outcome at 2 years. Pediatrics 2010;125(4):e852–e858. doi:10.1542/peds.2009-1960. PMID 20211949. verified
- Luyt K, Jary SL, Lea CL, et al. Drainage, irrigation and fibrinolytic therapy (DRIFT) for posthaemorrhagic ventricular dilatation: 10-year follow-up of a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2020;105(5):466–473. doi:10.1136/archdischild-2019-318231. PMID 32623370. verified
- Rela A, Jary S, Williams C, et al. Quality of life at a 10-year follow-up of children born preterm with post-hemorrhagic ventricular dilatation: a cohort study. Neonatology 2023;120(6):690–698. doi:10.1159/000533355. PMID 37678198. verified
- Fagundes W, Carretta LTA, Kotochinsky M, et al. Neuroendoscopic lavage in neonatal posthemorrhagic hydrocephalus: a systematic review and single-arm meta-analysis. J Neurosurg Pediatr 2026;38(4):512–520. doi:10.3171/2026.3.PEDS25406. PMID 42537225. verified
- Honeyman SI, Martin SC, Lawrence T, et al. Neuroendoscopic lavage for the management of neonatal post-haemorrhagic hydrocephalus: a systematic review and meta-analysis. Childs Nerv Syst 2025;41(1):385. doi:10.1007/s00381-025-07023-9. PMID 41310238. verified
- Thomale UW, Bogoslovskaia E, Knerlich-Lukoschus F, et al. Treatment of Posthemorrhagic Hydrocephalus in neonates (TROPHY) registry: surgical results from 6-month follow-up data. J Neurosurg Pediatr 2025;37(2):122–132. doi:10.3171/2025.7.PEDS25167. PMID 41349021. verified
- Mediratta S, Chari A, Battersby C, et al. Endoscopic lavage after intraventricular haemorrhage in neonates in the UK (ENLIVEN-UK): study protocol for a national randomised-controlled trial. Trials 2025;26(1):464. doi:10.1186/s13063-025-08952-1. PMID 41185020. verified
Verification (2026-11-19):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Reference 5 is online ahead of print.
- Numbers were checked against the PubMed abstracts. The SOPHH age and FOHR entry criteria come from reference 8's open-access full text, which states that its cohort followed the standardized SOPHH parameters.
- Reference 7's specific treatment thresholds (for example head-growth, fontanelle and ventricular-size triggers for temporization and conversion) are in its paywalled full text and could not be checked, so they are not given here. Read the original before quoting numbers.
- Reference 11's description of the DRIFT technique (tPA, two catheters) was confirmed in its open-access full text (PMC7547901).
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- PHH as one of the most common causes of infant shunting;
- germinal matrix pathophysiology and timing;
- the definitions of Papile grades I–IV (reference 1's abstract names four grades but doesn't define them);
- PVHI as a venous infarction and its link to hemiparesis;
- screening schedules;
- thalamo-occipital distance and FOHR as measures, and the lateness of clinical signs in preterm infants;
- typical weight and CSF-protein thresholds before shunting;
- why DRIFT didn't become standard practice;
- the NEL technique details;
- PHH shunt failure, infection and loculation, and lower ETV-CPC success in PHH;
- outcomes by grade.
- References 13–15 are observational and heterogeneous; reference 16 is a trial protocol without results.
- The figure is an original schematic.